Clinical Trial Update: The PROspera Kidney Transplant ACTIVE Rejection Assessment Registry (ProActive)

View source ↗

Summary

An observational registry (ProActive) sponsored by Natera to assess active rejection in kidney transplant recipients as part of the PROspera program. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplant Rejection

Drugs mentioned

• Prospera (donor-derived cell-free DNA assay)

Snippet

Sponsor: Natera, Inc. | Conditions: Kidney Transplant Rejection | Status: ACTIVE_NOT_RECRUITING